Annals of Internal Medicine · 2008 · 110 citations · 13 references
Public AffairsHealth PolicyPharmacoeconomicsCost-effectiveness AnalysisHealth EconomicsHealth Technology AssessmentComparative Effectiveness AssessmentCost-effectiveness ComparisonEconomic EvaluationHealth Care CostsHealthcare Cost AnalysisPharmacoeconomic EvaluationClinical Effectiveness MeasurementComparative Clinical EffectivenessComparative Cost-effectivenessCost-effectivenessMedical Cost AnalysisRelative Effectiveness Estimation
The American College of Physicians has called for a trusted national entity to generate comparative effectiveness data, defining it as the evaluation of relative clinical effectiveness, safety, and cost among multiple medical interventions for the same condition. This article argues for the creation of such an entity to develop cost‑effectiveness information. It reviews current reluctance to use cost‑effectiveness in the U.S., stresses its importance for all stakeholders, and offers specific recommendations for making this information available and useful to the public and patients.
The American College of Physicians recently highlighted the need to provide increased information comparing the effectiveness of health care interventions to ensure the rational and effective practice of medicine. Comparative effectiveness refers to the evaluation of the relative clinical effectiveness, safety, and cost of 2 or more medical services, drugs, devices, therapies, or procedures used to treat the same condition. The College further recommended the establishment of an adequately funded, trusted national entity that should prioritize, sponsor, or produce both comparative clinical and cost-effectiveness data. This article addresses the need for the proposed entity to develop cost-effectiveness information. It examines the current reluctance to develop and use cost-effectiveness in the United States; it argues for the importance of this information for all health care stakeholders; and it makes specific recommendations regarding how this information can best be made available and used for the good of the public and our patients.
13
Quality, Innovation, and Value for Money
Steven D. Pearson, M. D. Rawlins · JAMA · 2005 · 162 citations
Comparing Health System Performance In OECD Countries
Gerard F. Anderson, Peter S. Hussey · Health Affairs · 2001 · 151 citations